The emergence of generative artificial intelligence platforms in 2023, journal metrics, appreciation to reviewers and volunteers, and obituary

Abstract

The emergence of generative artificial intelligence platforms in 2023 and the effect of the COVID-19 pandemic on clinical performanceAfter ChatGPT's release on November 30, 2022, generative artificial intelligence (AI) fever was a hot topic in 2023. Many kinds of generative AI platforms appeared, including GPT-4, Bing, Gemini (former Bard), Claude.ai, Clova X, and Wrtn. The issues related to ChatGPT adoption discussed in research articles mainly dealt with passing tests, applicability in medical practice, and writing support [1].Many manuscripts on generative AI have also been submitted to this journal. Most of them were accepted if the methods and interpretations were sound. Out of them, my brief report on ChatGPT's performance on a parasitology exam, with a 60.8% correct answer rate [2], was the first article to be published in the journal on the performance of ChatGPT. Another remarkable article was written by a team of 1st year medical students. As a class assignment, they wrote an article comparing the performance of 6 generative AI platforms by information amount, accuracy, and relevance [3]. Their writing was quite impressive, with a core message focusing on the usefulness of generative AI platforms. The conclusion was also very informative-"A Korea-based company's generative AI, Clova X, showed 100% relevance to the queries in Korea, which is the best performance out of the 6 generative AI platforms. The experience of using generative AI in the classroom enhanced the authors' self-efficacy, which led to a heightened interest in the subject matter. " Dr. Ju Yoen Lee, a copyright law professor, wrote an article on AI authorship [4], which has also been a hot topic regarding the use of generative AI. She concluded,